318 related articles for article (PubMed ID: 15290747)
1. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.
Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM
J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747
[TBL] [Abstract][Full Text] [Related]
2. Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.
Schmeling H; Stephens S; Goia C; Manlhiot C; Schneider R; Luthra S; Stringer E; Feldman BM
Rheumatology (Oxford); 2011 May; 50(5):885-93. PubMed ID: 21156669
[TBL] [Abstract][Full Text] [Related]
3. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.
Ostrowski RA; Sullivan CL; Seshadri R; Morgan GA; Pachman LM
Arthritis Rheum; 2010 May; 62(5):1533-8. PubMed ID: 20213809
[TBL] [Abstract][Full Text] [Related]
4. Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease.
Scheja A; Elborgh R; Wildt M
J Rheumatol; 1999 Jun; 26(6):1377-81. PubMed ID: 10381059
[TBL] [Abstract][Full Text] [Related]
5. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
Christen-Zaech S; Seshadri R; Sundberg J; Paller AS; Pachman LM
Arthritis Rheum; 2008 Feb; 58(2):571-6. PubMed ID: 18240225
[TBL] [Abstract][Full Text] [Related]
6. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis.
Xu D; Huang CC; Kachaochana A; Morgan GA; Bonaldo MF; Soares MB; Costa F; Sarwark J; Sredni ST; Pachman LM
J Rheumatol; 2016 Jan; 43(1):161-8. PubMed ID: 26628598
[TBL] [Abstract][Full Text] [Related]
8. Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study.
Xu D; Kacha-Ochana A; Morgan GA; Huang CC; Pachman LM
Pediatr Rheumatol Online J; 2017 May; 15(1):42. PubMed ID: 28514969
[TBL] [Abstract][Full Text] [Related]
9. Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity.
Pachman LM; Morgan G; Klein-Gitelman MS; Ahsan N; Khojah A
Pediatr Rheumatol Online J; 2023 Oct; 21(1):118. PubMed ID: 37828536
[TBL] [Abstract][Full Text] [Related]
10. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.
Bode RK; Klein-Gitelman MS; Miller ML; Lechman TS; Pachman LM
Arthritis Rheum; 2003 Feb; 49(1):7-15. PubMed ID: 12579588
[TBL] [Abstract][Full Text] [Related]
11. Childhood dermatomyositis: serial microvascular studies.
Silver RM; Maricq HR
Pediatrics; 1989 Feb; 83(2):278-83. PubMed ID: 2464157
[TBL] [Abstract][Full Text] [Related]
12. Nailfold capillary microscopy in adults with inflammatory myopathy.
Selva-O'Callaghan A; Fonollosa-Pla V; Trallero-Araguás E; Martínez-Gómez X; Simeon-Aznar CP; Labrador-Horrillo M; Vilardell-Tarrés M
Semin Arthritis Rheum; 2010 Apr; 39(5):398-404. PubMed ID: 19022479
[TBL] [Abstract][Full Text] [Related]
13. Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele.
Fedczyna TO; Lutz J; Pachman LM
Clin Immunol; 2001 Aug; 100(2):236-9. PubMed ID: 11465953
[TBL] [Abstract][Full Text] [Related]
14. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.
Gitiaux C; De Antonio M; Aouizerate J; Gherardi RK; Guilbert T; Barnerias C; Bodemer C; Brochard-Payet K; Quartier P; Musset L; Chazaud B; Desguerre I; Bader-Meunier B
Rheumatology (Oxford); 2016 Mar; 55(3):470-9. PubMed ID: 26424834
[TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
16. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
Sato LT; Kayser C; Andrade LE
Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
[TBL] [Abstract][Full Text] [Related]
17. Nailfold capillary abnormalities in Behçet's disease.
Vaiopoulos G; Pangratis N; Samarkos M; Hatzinicolaou P; Mavropoulos S; Tzonou A; Kaklamanis P
J Rheumatol; 1995 Jun; 22(6):1108-11. PubMed ID: 7674238
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
[TBL] [Abstract][Full Text] [Related]
19. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes.
Guzmán J; Petty RE; Malleson PN
J Rheumatol; 1994 Apr; 21(4):739-43. PubMed ID: 8035403
[TBL] [Abstract][Full Text] [Related]
20. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
Wang A; Morgan GA; Paller AS; Pachman LM
J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
